182 related articles for article (PubMed ID: 28734033)
1. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
[TBL] [Abstract][Full Text] [Related]
2. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
[TBL] [Abstract][Full Text] [Related]
3. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
4. Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.
Jaskulski S; Jung AY; Huebner M; Poschet G; Hell R; Hüsing A; Gonzalez-Maldonado S; Behrens S; Obi N; Becher H; Chang-Claude J
Nutr Cancer; 2020; 72(7):1155-1169. PubMed ID: 31617773
[TBL] [Abstract][Full Text] [Related]
5. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
Zeleniuch-Jacquotte A; Adlercreutz H; Akhmedkhanov A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):885-9. PubMed ID: 9796633
[TBL] [Abstract][Full Text] [Related]
6. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
[TBL] [Abstract][Full Text] [Related]
7. Serum enterolactone and prognosis of postmenopausal breast cancer.
Buck K; Vrieling A; Zaineddin AK; Becker S; Hüsing A; Kaaks R; Linseisen J; Flesch-Janys D; Chang-Claude J
J Clin Oncol; 2011 Oct; 29(28):3730-8. PubMed ID: 21900115
[TBL] [Abstract][Full Text] [Related]
8. Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
[TBL] [Abstract][Full Text] [Related]
9. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
[TBL] [Abstract][Full Text] [Related]
10. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
[TBL] [Abstract][Full Text] [Related]
11. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
Power KA; Ward WE; Chen JM; Saarinen NM; Thompson LU
Bone; 2006 Jul; 39(1):117-24. PubMed ID: 16469549
[TBL] [Abstract][Full Text] [Related]
12. Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis.
Micek A; Godos J; Brzostek T; Gniadek A; Favari C; Mena P; Libra M; Del Rio D; Galvano F; Grosso G
Nutr Rev; 2021 Jan; 79(1):42-65. PubMed ID: 32632445
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo.
Saarinen NM; Abrahamsson A; Dabrosin C
Int J Cancer; 2010 Aug; 127(3):737-45. PubMed ID: 19924815
[TBL] [Abstract][Full Text] [Related]
14. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.
Piller R; Verla-Tebit E; Wang-Gohrke S; Linseisen J; Chang-Claude J
J Nutr; 2006 Jun; 136(6):1596-603. PubMed ID: 16702327
[TBL] [Abstract][Full Text] [Related]
15. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
16. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
17. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
18. Plasma phytoestrogens concentration and risk of colorectal cancer in two different Asian populations.
Ko KP; Yeo Y; Yoon JH; Kim CS; Tokudome S; Ngoan LT; Koriyama C; Lim YK; Chang SH; Shin HR; Kang D; Park SK; Kang CH; Yoo KY
Clin Nutr; 2018 Oct; 37(5):1675-1682. PubMed ID: 28778370
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum enterolactone, genistein, and daidzein in a dietary intervention study in Finland.
Stumpf K; Pietinen P; Puska P; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1369-72. PubMed ID: 11142423
[TBL] [Abstract][Full Text] [Related]
20. The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study.
Zaineddin AK; Buck K; Vrieling A; Heinz J; Flesch-Janys D; Linseisen J; Chang-Claude J
Nutr Cancer; 2012; 64(5):652-65. PubMed ID: 22591208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]